 [6] 
  After recently learning of Health Canadaâ€™s December 12, 2005 decision, the Applicant filed the present application for judicial review on November 10, 2006, requesting among others: (1) an Order confirming that Apotex must comply with subsection 5(1) of the PMNOC Regulations, as amended on October 5, 2006, in what concerns Apo-perindopril in 8 mg tablets and (2) an Order prohibiting the Minister of Health from issuing a NOC to Apotex in respect of Apo-perindopril in 8 mg tablets.